AI Article Synopsis
- Bayer Agriculture BV submitted a dossier for the renewal of authorization for genetically modified maize MON 810 to the European Food Safety Authority (EFSA), focusing on its safety for food and feed uses but not cultivation in the EU.
- The EFSA's GMO Panel evaluated new data, including environmental monitoring reports and updated studies, to identify any potential new hazards or uncertainties related to the maize.
- The Panel concluded that there is no evidence of new risks or changes since the original assessment, indicating that the genetically modified maize remains safe based on the identical DNA sequence.
Article Abstract
Following the submission of dossier GMFF-2022-9450 under Regulation (EC) No 1829/2003 from Bayer Agriculture BV, the Panel on Genetically Modified Organisms of the European Food Safety Authority was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application for the insect protected genetically modified maize MON 810, for food and feed uses (including pollen), excluding cultivation within the European Union. The data received in the context of this renewal application contained post-market environmental monitoring reports, an evaluation of the literature retrieved by a scoping review, additional studies performed by or on behalf of the applicant and updated bioinformatics analyses. The GMO Panel assessed these data for possible new hazards, modified exposure or new scientific uncertainties identified during the authorisation period and not previously assessed in the context of the original application. Under the assumption that the DNA sequence of the event in maize MON 810 considered for renewal is identical to the sequence of the originally assessed event, the GMO Panel concludes that there is no evidence in dossier GMFF-2022-9450 for new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment on maize MON 810.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10797474 | PMC |
| http://dx.doi.org/10.2903/j.efsa.2024.8489 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Establishing best practices for insect resistance management: a new paradigm for genetically engineered toxins in cotton expressing Mpp51Aa2.
J Econ Entomol
January 2025
Department of Entomology and Plant Pathology and the North Carolina Plant Sciences Institute, NC State University, Raleigh, NC, USA.
Debate over resistance management tactics for genetically engineered (GE) crops expressing insecticidal toxins is not new. For several decades, researchers, regulators, and agricultural industry scientists have developed strategies to limit the evolution of resistance in populations of lepidopteran and coleopteran pests. A key attribute of many of these events was insecticide resistance management (IRM) strategies designed around a presumed high-dose expression sufficient to kill 99.
View Article and Find Full Text PDFIncipient resistance of the African maize stemborer, Busseola fusca (Lepidoptera: Noctuidae) to Cry2Ab2 maize in South Africa.
Pest Manag Sci
November 2024
IPM Program, Unit for Environmental Science and Management, North-West University, Potchefstroom, South Africa.
Background: Resistance of Busseola fusca (Lepidoptera: Noctuidae) to Cry1Ab was documented in 2006, 7 years after the first cultivation of MON 810 in South Africa. This was mitigated by introducing a second-generation Bacillus thuringiensis (Bt) maize (MON 89034), which contains the Cry1A.105 and Cry2Ab2 proteins.
View Article and Find Full Text PDFDistribution of moniliformin in industrial maize milling and flaking process.
Mycotoxin Res
November 2024
Department of Sustainable Crop Production-DIPROVES, Università Cattolica del Sacro Cuore, Via Emilia Parmense 84, 29122, Piacenza, Italy.
Moniliformin (MON) is a widespread emerging mycotoxin often occurring in maize at significant levels. Few published studies investigated MON redistribution in maize-derived products for human consumption; to better understand this issue, 5 maize lots with different levels of MON contamination were processed following an industrial milling process to evaluate the redistribution of the mycotoxin in final products (grits), by-products destined to feed (bran and flour) and cleaning waste. MON was quantified by LC-MS/MS after the purification step through the SPE column; moreover, a confirmatory method based on MON derivatization with 1,2-diamino-4,5-dichlorobenzene was developed.
View Article and Find Full Text PDFArticle Synopsis
- The European Food Safety Authority (EFSA) reviewed the 2022 environmental monitoring report on the cultivation of Cry1Ab-expressing maize MON 810, finding no evidence of negative impacts from its cultivation.
- Spanish and Portuguese farmers generally complied with refuge requirements, but there are concerns about adherence in larger farming clusters, and some potential for decreased susceptibility in certain corn borer populations.
- EFSA highlighted the need for better monitoring of insect resistance and recommended measures to protect sensitive non-target butterfly species from maize MON 810 pollen, as several previous recommendations remain unaddressed.
Genetically modified maize MON 95275 was developed to confer protection to certain coleopteran species. These properties were achieved by introducing the , and expression cassettes. The molecular characterisation data and bioinformatic analyses reveal similarity to known toxins, which was further assessed.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!